NXGL NEXGEL, Inc: רווח למניה ב-12 החודשים האחרונים

Risks associated with the slow development of the retail network and production scaling are putting pressure on the business, as illustrated by the rolling annual EPS growth chart. The current value of this metric is -78.70. The prospects for NEXGEL, Inc. (NXGL) are based on the growth of B2B orders and e-commerce sales, while its competitive advantage is driven by patented electronic cross-linking hydrogel technology for efficient drug delivery.

For an investor assessing the issuer's financial stability, this indicator measures the growth rate of net earnings per share over a rolling year, revealing the actual efficiency of shareholder equity generation while eliminating seasonal distortions. By analyzing the rolling year EPS growth, one can evaluate how the synergy between B2B contracts and retail sales of hydrogels at NEXGEL, Inc. (NXGL) converts into stable profit growth.